MedTrace Logo

Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis

NCT00942006 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2009-07-20

No results posted yet for this study

Summary

The investigators will compare doxycycline and ceftriaxone in treatment of patients with suspected early Lyme neuroborreliosis and normal CSF cell count. The study hypothesis is that the efficacy and adverse effects of both antibiotics are comparable.

Conditions

  • Suspected Early Lyme Neuroborreliosis

Interventions

DRUG

doxycycline

100 mg bid, 14 days

DRUG

ceftriaxone

2g x 1 iv, 14 days

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Principal Investigators

  • Franc Strle, MD PhD · UMC Ljubljana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-11-30
Completion
2011-11-30

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00942006 on ClinicalTrials.gov